Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) fell 7.7% during mid-day trading on Thursday . The stock traded as low as $10.14 and last traded at $10.14. 1,300 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Stock Down 7.7 %
The company’s 50 day moving average price is $10.14 and its 200-day moving average price is $10.14.
Biotech Acquisition Company Profile
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Featured Articles
- Five stocks we like better than Biotech Acquisition
- Stock Dividend Cuts Happen Are You Ready?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks to Buy While Others Stay on the Sidelines
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
